Stocks in Investment Track: Targetted Cancer Therapy
| Ticker & Name | Change(%) & Price | MarketCap ($B) | 5Y Return (%) | 1Y Return (%) | YTD Return (%) | 1M Return (%) | 5D Return (%) |
|---|---|---|---|---|---|---|---|
CELC Celcuity, Inc | -1.06% $112.93 | 5.46 | 665.6 | 1115.6 | 12.3 | 4.2 | 2.4 |
GLUE Monte Rosa Therapeutics, Inc | 4.37% $17.17 | 1.31 | -18.9 | 287.5 | 12.1 | -7.1 | 9.2 |
ARVN Arvinas, Inc | 6.88% $11.33 | 0.68 | -82.7 | 61.1 | -1.2 | -15.3 | 3.7 |
RCKT Rocket Pharmaceuticals, Inc | 1.11% $3.62 | 0.393 | -91.9 | -37.6 | 4.6 | -27.1 | -22.6 |
GLSI Greenwich LifeSciences, Inc | -4.41% $22.96 | 0.335 | -33.8 | 147.9 | 17.9 | -16.1 | -11.6 |
IRWD Ironwood Pharmaceuticals, Inc | 11.11% $3.9 | 0.611 | -64.1 | 176.5 | -8.6 | 9.2 | 22.2 |
Leader of Invesment Track: Targetted Cancer Therapy
Click on "Go" to get the latest result